WebbYuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs. Pudong, Shandong, China 11-50 Seed Private 65,436 Highlights Total Funding Amount CN¥200M Investors 7 Similar Companies 8 Recent News & Activity Funding Round • Mar 14, 2024 WebbYL Biont is a collection of research, production, sales as one of the leading international biological high-tech enterprise. the company focused on the immune detection reagents of independent research and development, …
MedChemExpress: Master of Bioactive Molecules Inhibitors, …
http://sangon.bioon.com.cn/index_11665.html WebbShanghai Longyu biotech Co., Ltd. is a company engaged in the import and export of pharmaceutical and chemical raw materials and intermediates.It has been actively committed to the collection and development of new and old products, Adhering to the principle of "Honesty-oriented, customer First" and after long-term steady development, … try 29.99 to hkd
Shanghai Life Bio-Tech Co., LTD
WebbShanghai SIMR Biotechnology Co.,Ltd. ABOUT SIMR Company Profile Management Team Functional Team SAB Vision & Mission Milestones Investors; R&D Research Field Pipeline Translational Center; ... Shanghai SIMR Biotech received 150 million Chinese Yuan C1 r On November 8, 2024, Shanghai SIMR Biotech (here in after referred to as "SIMR Bio " or the ... WebbYinai Shanghai Biotechnology Co Ltd - Company Profile and News - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people … WebbYake Biotechnology Ltd. Report issue. Government Phase 1 Phase 2. Organization Overview. First Clinical Trial. 2024 ... Shanghai YaKe Biotechnology Ltd. Yake Biotechnology Ltd. Active Ingredients. Drugs in Phase 2 Trials (3) cd19 car-t cells ... try 290